Cell cytometry market seen reaching $2.62 billion by 2030

The Business Research Company says the global cell cytometry market will grow from $1.75 billion in 2026 to $2.62 billion by 2030, driven by personalized medicine, immunotherapy research and single-cell analysis. North America leads the market now, while Asia-Pacific is projected to grow fastest.

Why it matters: - Cell cytometry is becoming more central to research and clinical diagnostics as demand grows for more precise analysis of cells and immune responses. - The market forecast points to continued spending on tools that support cancer research, drug discovery, personalized medicine and high-throughput analysis. - The shift matters for labs, drug developers and diagnostic providers because cytometry is increasingly tied to treatment selection and disease monitoring.

What happened: - The Business Research Company released its Cell Cytometry Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report pegs the global cell cytometry market at $1.75 billion in 2026. - The market is forecast to reach $2.62 billion by 2030. - The report projects a 10.7% compound annual growth rate from 2026 to 2030. - North America held the largest regional market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - The market grew from $1.57 billion in 2025 to $1.75 billion in 2026, a 11.0% CAGR. - Historic growth was driven by cancer research, broader flow cytometry use in diagnostics, pharmaceutical drug discovery, automated laboratory systems and better cytometry reagents. - Forecast growth is tied to expanding use in precision medicine, higher investment in immunotherapy research, single-cell analysis, high-throughput cell analysis and digital analytics in cytometry platforms. - Emerging trends include high-parameter flow cytometry, AI-powered cell analysis software, immune profiling, automated cytometry workflows and single-cell analysis techniques. - Cell cytometry measures the physical and chemical properties of cells or particles suspended in fluid. - The technique uses a laser or electrical field to detect size, shape, granularity and specific proteins or molecules. - Cell cytometry is used in biology, medical diagnostics and research for immune profiling, cancer diagnosis and treatment-response evaluation. - The report’s regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report also includes key technologies and future trend analysis. - A free sample is available through the market report sample request. - The full report is available at the cell cytometry market report.

Between the lines: - Personalized medicine is a major demand driver because it relies on detailed patient-specific cell analysis to identify disease markers and guide treatment choices. - The report cites FDA approvals of 16 new personalized therapies for rare diseases in 2023, up from six in 2022, as evidence of growing momentum in personalized treatment. - The forecast suggests cytometry vendors will compete more on automation, software and data analysis rather than instrument performance alone. - The emphasis on AI and single-cell analysis indicates the market is moving toward more complex, higher-value workflows.

What's next: - Market growth is likely to continue as immunotherapy, precision medicine and single-cell research expand. - Adoption of automated workflows and digital analytics should increase as labs seek faster and more scalable analysis. - Demand for immune profiling and high-parameter systems is expected to remain a key product theme over the forecast period.

The bottom line: - Cell cytometry is shifting from a specialized research tool to a broader platform for precision diagnostics and advanced biomedical analysis, and the market outlook remains strong.